teleo-codex/domains/health/V28 risk model update and 2027 chart review exclusion are structurally complementary reforms targeting coding breadth and coding method as distinct dimensions of MA upcoding.md

type	domain	description	confidence	source	created	depends_on	challenged_by
claim	health	V28 reduces the universe of diagnoses that map to HCC payments (what gets coded) while the chart review exclusion eliminates retrospective coding not tied to clinical encounters (how it gets coded), making their combined savings effect additive and their combined structural impact the most significant MA reform since program inception	likely	Commonwealth Fund risk adjustment explainer January 2026; CMS V28 implementation documentation 2024-2026; CMS 2027 Advance Notice February 2026	2026-03-12	CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring

V28 risk model update and 2027 chart review exclusion are structurally complementary reforms targeting coding breadth and coding method as distinct dimensions of MA upcoding

The two most significant CMS regulatory interventions in MA economics — the V24-to-V28 model transition and the proposed 2027 chart review exclusion — are often discussed as if they address the same problem. They do not. They target orthogonal dimensions of upcoding and their effects are additive, not redundant.

V28 (implemented 2024–2026): What gets coded

The V28 model update significantly decreased the number of diagnosis codes that map to HCCs (Hierarchical Condition Categories), while also increasing the total number of HCC categories. The practical effect: a narrower set of diagnoses triggers payment adjustments, and the diagnostic categories are more granular. Plans that submitted broad, lower-specificity diagnoses under V24 — capturing payment from codes that mapped loosely to HCCs — lose that revenue under V28. CMS estimated V28 would save $7.6 billion in 2024 alone, revealing the scale of payment generated by V24 diagnoses that V28 considers insufficiently specific to justify the uplift.

The V28 transition is being phased in over 2024–2026 with a full implementation by 2026. The phase-in is gradual to avoid abrupt market disruption, but the direction is clear: fewer diagnoses qualify for risk score credit, and those that do require higher specificity.

2027 Chart Review Exclusion: How it gets coded

The chart review exclusion proposal (CMS 2027 Advance Notice) targets a different variable: the method by which diagnoses are collected from patients. Specifically, diagnoses from "unlinked chart review records" — retrospective reviews of medical records not tied to a documented clinical encounter — would be excluded from risk score calculations. Diagnoses are allowed only when tied to an actual encounter.

This closes the retrospective coding loop. Under current rules, plans can review years of medical records to find additional codeable conditions and submit them for risk score credit regardless of whether any clinician documented those conditions during an actual patient visit. In-home health assessments — visits structured primarily to capture diagnosis codes rather than deliver care — are a related mechanism that the exclusion targets. The projected savings are more than $7 billion in 2027 from this exclusion alone.

Why the complementarity matters

V28 reduces the value of any given diagnosis code submission by narrowing what maps to payment. The chart review exclusion reduces the quantity of diagnosis codes that can be submitted by eliminating a major collection pathway. These are independent levers:

• A plan could adapt to V28 by shifting to higher-specificity diagnosis codes while continuing retrospective chart review. The chart review exclusion forecloses that adaptation.
• A plan could adapt to the chart review exclusion by restricting retrospective coding to encounter-linked records. V28 simultaneously reduces the payment credit those encounter-linked codes generate.

The two reforms together constitute the most significant structural challenge to MA economics since the program's expansion — not because either is unprecedented alone, but because they close the system from two directions simultaneously. Industry warnings about benefit cuts and market exits emerge specifically from the combined pressure, not from either reform in isolation.

The V28 phase-in runs concurrently with the chart review exclusion proposal. By 2027, the MA coding landscape will have contracted both in the universe of mappable diagnoses (V28) and in the method by which diagnoses can be retrospectively captured (chart review exclusion). Plans whose economics depend on either lever face compounded pressure.

---

Relevant Notes:

• CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring — detailed mechanics of the chart review exclusion and its effect on vertical integration profit models
• MA diagnosis codes fail OIG audit validation at 70 percent rate indicating systematic upcoding is the structural baseline not edge-case fraud — the scale of unsupported coding that both reforms target
• Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening — purpose-built plans unaffected by either reform because their coding derives from genuine encounters
• four competing payer-provider models are converging toward value-based care with vertical integration dominant today but aligned partnership potentially more durable — the dual reform accelerates the structural shift away from acquisition-based integration

Topics:

• health/_map.md